Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Cory Kasimov
Recent news which mentions Cory Kasimov
Biogen downplays ‘premature’ talk of competition for SMA drug Spinraza
July 23, 2019
Tags
Novartis
Biogen Inc/
Biotech
From
Business Journals
Analysts Raise Price Targets On GW Pharma's Positive Earnings, Epidiolex Results
May 07, 2019
Tickers
GWPH
UNH
Tags
Epidiolex
Matthew Holt
Earnings
From
Benzinga
Juno Therapeutics Price Target Cut From $63 To $39 At JPMorgan
July 08, 2016
Tickers
JUNO
Tags
Analyst Ratings
JPMorgan
Benzinga
From
Benzinga
Clovis Investors Lose Roci Value Entirely, JPMorgan Sees Clovis Worth Just What Ruca Can Pay: $15/Share
April 13, 2016
Tickers
CLVS
Tags
Downgrades
Benzinga
CLVS
From
Benzinga
Puma Biotechnology Analysts Are Getting Nervous, But Still Going Long
March 29, 2016
Tickers
PBYI
TECH
Tags
Analyst Ratings
NDA
Long Ideas
From
Benzinga
JP Morgan Upgrades Celgene, Says 'Too Cheap To Ignore'
October 01, 2015
Tickers
CELG
Tags
Benzinga
Analyst Ratings
Cory Kasimov
From
Benzinga
Bluebird Bio's Positive LentiGlobin Data: Wall Street Responds
June 15, 2015
Tickers
BLUE
Tags
BLUE
Analyst Ratings
General
From
Benzinga
JP Morgan Downgrades MannKind; Jefferies Also Comments
May 11, 2015
Tickers
MNKD
Tags
Price Target
Analyst Color
Cory Kasimov
From
Benzinga
Analysts Respond To Pharmacyclics' Q4 Results
February 19, 2015
Tickers
PCYC
Tags
Cory Kasimov
PCYC
J/P/ Morgan
From
Benzinga
Gilead Sciences Spikes Higher As Barron's Suggests Looking Beyond Hepatitis-C
December 05, 2014
Tickers
GILD
Tags
JP Morgan
GILD
Intraday Update
From
Benzinga
Novavax, Inc. Jumps 7% Amid JP Morgan Initiation
October 07, 2014
Tickers
NVAX
Tags
Benzinga
Initiation
Analyst Ratings
From
Benzinga
J.P. Morgan Sees Sangamo Biosciences, Inc. As Attractive Investment Opportunity
September 09, 2014
Tickers
SGMO
Tags
J/P/ Morgan
Cory Kasimov
Analyst Color
From
Benzinga
UPDATE: J.P. Morgan Initiates Coverage On Sangamo Biosciences On Potentially Disruptive Future
August 01, 2014
Tickers
SGMO
Tags
J/P/ Morgan
Cory Kasimov
Benzinga
From
Benzinga
UPDATE: Vivus Down Nearly 12% After JP Morgan Downgrade on Lackluster Qsymia News
February 25, 2014
Tickers
VVUS
Tags
JP Morgan
Price Target
US9285511005
From
Benzinga
UPDATE: J.P. Morgan Reiterates on Keryx Biopharmaceuticals on Model Update After Positive NDD-CKD Data
November 07, 2013
Tickers
KERX
Tags
Analyst Ratings
Benzinga
KERX
From
Benzinga
UPDATE: J.P. Morgan Initiates bluebird bio at Overweight on Unique & Necessary Medical Products
July 15, 2013
Tickers
BLUE
Tags
Cory Kasimov
Analyst Color
BLUE
From
Benzinga
UPDATE: J.P. Morgan Downgrades Rigel Pharmaceuticals to Neutral Following AZN Decision
June 04, 2013
Tickers
RIGL
Tags
Analyst Color
Cory Kasimov
J/P/ Morgan
From
Benzinga
UPDATE: J.P. Morgan Raises PT on Aegerion Pharmaceuticals in Continuing Doc Rounds Series
May 29, 2013
Tickers
AEGR
Tags
Cory Kasimov
J/P/ Morgan
Price Target
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.